product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
MUC1 (VU4H5) Mouse mAb
catalog :
4538
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
VU4H5
reactivity :
human
application :
western blot, immunohistochemistry, immunocytochemistry, immunoprecipitation, flow cytometry
citations: 9
Published Application/Species/Sample/DilutionReference
  • immunocytochemistry; human; fig 1
  • western blot; human; fig 1
Cai X, Dai Z, Reeves R, Caballero Benítez A, Duran K, Delrow J, et al. Autonomous stimulation of cancer cell plasticity by the human NKG2D lymphocyte receptor coexpressed with its ligands on cancer cells. PLoS ONE. 2014;9:e108942 pubmed publisher
  • western blot; human
Castorina A, Giunta S. Mucin 1 (MUC1) signalling contributes to increase the resistance to cell death in human bronchial epithelial cells exposed to nickel acetate. Biometals. 2014;27:1149-58 pubmed publisher
Huang W, Chan M, Chen M, Tsai T, Chen Y. Modulation of macrophage polarization and lung cancer cell stemness by MUC1 and development of a related small-molecule inhibitor pterostilbene. Oncotarget. 2016;7:39363-39375 pubmed publisher
Zhou N, Wang R, Zhang Y, Lei Z, Zhang X, Hu R, et al. Staurosporine Induced Apoptosis May Activate Cancer Stem-Like Cells (CD44(+)/CD24(-)) in MCF-7 by Upregulating Mucin1 and EpCAM. J Cancer. 2015;6:1049-57 pubmed publisher
Chiu W, Ling T, Chiang H, Lin H, Huang C. Monitoring Cluster Ions Derived from Aptamer-Modified Gold Nanofilms under Laser Desorption/Ionization for the Detection of Circulating Tumor Cells. ACS Appl Mater Interfaces. 2015;7:8622-30 pubmed publisher
Li L, Fridley B, Kalari K, Niu N, Jenkins G, Batzler A, et al. Discovery of genetic biomarkers contributing to variation in drug response of cytidine analogues using human lymphoblastoid cell lines. BMC Genomics. 2014;15:93 pubmed publisher
Goudarzi H, Iizasa H, Furuhashi M, Nakazawa S, Nakane R, Liang S, et al. Enhancement of in vitro cell motility and invasiveness of human malignant pleural mesothelioma cells through the HIF-1?-MUC1 pathway. Cancer Lett. 2013;339:82-92 pubmed publisher
Bozkaya G, Korhan P, Cokakli M, Erdal E, Sagol O, Karademir S, et al. Cooperative interaction of MUC1 with the HGF/c-Met pathway during hepatocarcinogenesis. Mol Cancer. 2012;11:64 pubmed publisher
Lau S, Shields D, Murphy E, Desgrosellier J, Anand S, Huang M, et al. EGFR-mediated carcinoma cell metastasis mediated by integrin ?v?5 depends on activation of c-Src and cleavage of MUC1. PLoS ONE. 2012;7:e36753 pubmed publisher
product information
SKU :
4538S
Product-Name :
MUC1 (VU4H5) Mouse mAb
Size :
100 ul
Price-(USD) :
235 USD
Species-x-Reactivity :
H
Applications :
Flow cytometry
Product-Category :
Adhesion/ECM
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Monoclonal Antibody
MW :
230, 400
Host :
Mouse
Target :
MUC1
Primary-Protein :
MUC1
Alt-Names :
Breast carcinoma-associated antigen DF3,CD227,Carcinoma-associated mucin,DF3 antigen,EMA,Episialin,H23 antigen,H23AG,KL-6,MAM6,MUC-1,MUC-1/SEC,MUC-1/X,MUC1,MUC1-CT,MUC1-NT,MUC1-alpha,MUC1-beta,MUC1/ZD,Mucin-1,Mucin-1 subunit alpha,Mucin-1 subunit beta,PEM,PEMT,PUM,Peanut-reactive urinary mucin,Polymorphic epithelial mucin,Tumor-associated epithelial membrane antigen,Tumor-associated mucin,mucin 1, cell surface associated,mucin 1, transmembrane,tumor associated epithelial mucin
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.